Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1156 AL 1170

Protein Amyloidogenesis Investigated by Small Angle Scattering

Ricci C, Spinozzi F, Mariani P, Ortore MG.

Curr Pharm Des. 2016;22(26):3937-49. doi: 10.2174/1381612822666160519113237.

Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche

Luarte A, Bátiz LF, Wyneken U, Lafourcade C.

Stem Cells Int. 2016;2016:5736059. doi: 10.1155/2016/5736059. Epub 2016 Apr 19.

The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D

Grant WB.

Dermatoendocrinol. 2016 Jan 8;8(1):e1137400. doi: 10.1080/19381980.2015.1137400. eCollection 2016 Jan-Dec.

Co-occurrence of multiple sclerosis and Parkinson disease

Shaygannejad V, Shirmardi M, Dehghani L, Maghzi H.

Adv Biomed Res. 2016 Apr 21;5:75. doi: 10.4103/2277-9175.180993. eCollection 2016.

Estrogens, Neuroinflammation, and Neurodegeneration

Villa A, Vegeto E, Poletti A, Maggi A.

Endocr Rev. 2016 Aug;37(4):372-402. doi: 10.1210/er.2016-1007. Epub 2016 May 19.

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease

Michel PP, Hirsch EC, Hunot S.

Neuron. 2016 May 18;90(4):675-91. doi: 10.1016/j.neuron.2016.03.038.

Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease

Colacurcio DJ, Nixon RA.

Ageing Res Rev. 2016 Dec;32:75-88. doi: 10.1016/j.arr.2016.05.004. Epub 2016 May 16.

Arachnophobia alleviated by subthalamic nucleus stimulation for Parkinson's disease

Allert N, Gippert SM, Sajonz BE, Nelles C, Bewernick B, Schlaepfer TE, Coenen VA.

J Neural Transm (Vienna). 2016 Jun;123(6):631-5. doi: 10.1007/s00702-016-1546-1. Epub 2016 May 19.

Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's Disease

Hickey P, Stacy M.

Front Neurosci. 2016 Apr 28;10:173. doi: 10.3389/fnins.2016.00173. eCollection 2016.

One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug

Hughes RE, Nikolic K, Ramsay RR.

Front Neurosci. 2016 Apr 25;10:177. doi: 10.3389/fnins.2016.00177. eCollection 2016.

[Cerebral venous thrombosis in a Parkinson's disease patient: An unusual case report with low-dose clozapine]

Colin O, Quillet A, Benatru I, Houeto JL, Lafay-Chebassier C, Pérault-Pochat MC.

Therapie. 2016 Oct;71(5):521-524. doi: 10.1016/j.therap.2016.02.030. Epub 2016 Apr 11.

Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile

Jaeschke RR, Sowa-Kućma M, Pańczyszyn-Trzewik P, Misztak P, Styczeń K, Datka W.

Pharmacol Rep. 2016 Aug;68(4):748-55. doi: 10.1016/j.pharep.2016.04.002. Epub 2016 Apr 22.

Activities of daily living questionnaire from patients' perspectives in Parkinson's disease: a cross-sectional study

Lee SY, Kim SK, Cheon SM, Seo JW, Kim MA, Kim JW.

BMC Neurol. 2016 May 21;16:73. doi: 10.1186/s12883-016-0600-9.

Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease

Vogt Weisenhorn DM, Giesert F, Wurst W.

J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):8-26. doi: 10.1111/jnc.13670. Epub 2016 Jun 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias